Drug
Indometacin
Indometacin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_4
1
25%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
unknown375%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis
NCT05637281
unknown
Study on Indomethacin-responsive Headaches
NCT03967483
completedphase_4
Indomethacin and Mechanisms Underlying Risk of Falling
NCT00462111
unknownearly_phase_1
Validation of New Tests for Gastrointestinal (GI) Permeability
NCT00943345
Clinical Trials (4)
Showing 4 of 4 trials
NCT05637281Not Applicable
Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis
NCT03967483
Study on Indomethacin-responsive Headaches
NCT00462111Phase 4
Indomethacin and Mechanisms Underlying Risk of Falling
NCT00943345Early Phase 1
Validation of New Tests for Gastrointestinal (GI) Permeability
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4